Post-Hypoxic Cells Promote Metastatic Recurrence after Chemotherapy Treatment in TNBC
Hypoxia occurs in 90% of solid tumors and is associated with treatment failure, relapse, and mortality. HIF-1α signaling promotes resistance to chemotherapy in cancer cell lines and murine models via multiple mechanisms including the enrichment of breast cancer stem cells (BCSCs). In this work, we u...
Guardado en:
Autores principales: | Inês Godet, Mahelet Mamo, Andrea Thurnheer, D. Marc Rosen, Daniele M. Gilkes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/edee0cfbbc51437ca7bef0f721d1a1a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Breast Cancer Recurrence Survival Among Iranian Patients; A 17-Year Retrospective Cohort Study
por: Amirreza Ehsani, et al.
Publicado: (2021) -
Metastatic Breast Cancer to the Urinary Bladder in the Caribbean
por: Saara Mohammed, et al.
Publicado: (2021) -
Opioids and Breast Cancer Recurrence: A Systematic Review
por: Merlino Lucia, et al.
Publicado: (2021) -
Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study
por: Lindsay J. Collin, et al.
Publicado: (2021) -
MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
por: Cao,Danxia, et al.
Publicado: (2020)